Home

Les médicaments génériques sont aussi de qualité, sûrs et efficaces.

L’agence fédérale des médicaments et des produits de santé (afmps)
lance une campagne visant à souligner la qualité, la sécurité et l’efficacité des médicaments génériques.

Clicquez iciExternal link pour plus d’information. 

Campagne_générique

Spot 1 (MP3, 1.15 MB)

Spot 2 (MP3, 1.15 MB)

Human use

Veterinary use

A clear vision of the future - Annual report 2013

image RA 2013 cover

 The annual report “A clear vision of the future – Annual report 2013” is available :

♦ in English (PDF, 8.4 MB) - Flipbook
External link
♦ in French (PDF, 12.73 MB) - FlipbookExternal link
♦ in Dutch (PDF, 14.38 MB) - FlipbookExternal link

 You can also ask for a paper copy of this annual report (as long as available) by mail to: comm@fagg-afmps.be

 

NEWS

  • VIG-NEWS: January 2015 Edition

    03-02-2015

    The new edition of the electronic newsletter "VIG-NEWS" of the federal agency for medicines and health products (famhp) is now available. The VIG-NEWS is a selection of recent news concerning pharmacovigilance from different sources.

    read more
  • Call Center “registration”: Expansion team in 2015

    21-01-2015

    Due to an underemployment within the Call Center Registration in 2014, this resulted in a delay in the processing of the daily requests send to registration@fagg.be. In the meantime the team has been expanded and a procedure has been worked out in order to absorb the delayed requests. As for the new requests, a workflow has been worked out in order to increase the efficiency.

    read more
  • Supply shortages for HAVRIX 1440 and HAVRIX JUNIOR 720 (GSK)

    12-01-2015

    Due to a reduction in the manufacturing capacity for the vaccines HAVRIX 1440 and HAVRIX JUNIOR 720 (GSK), used to protect adults and children against hepatitis A, and in order to limit the impact of these supply shortages, alternatives are being proposed The Superior Health Council (SHC) details the correct use of the proposed alternatives in advice number 9260: Recommendation concerning the risk on the shortage supply for hepatitis A vaccine.

    read more

ALL NEWS

Last updated on 04 May 2015

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

Newsletter

Subscribe to our newsletter

Your e-mail